缺血性心肌病外科治疗后左心室功能恢复的发生率、决定因素与临床影响
该回顾性研究分析490例LVEF≤40%的缺血性心肌病患者接受CABG,随访超声心动图评估左心室功能恢复情况。193例(39.4%)未恢复,10年总生存率恢复组53.9%显著高于未恢复组31.4%(P<0.001)。术前左室收缩末径和双侧胸廓内动脉移植是独立预测因素,未恢复与全因死亡显著相关(HR 2.14)。
要点
- 约40%缺血性心肌病CABG患者左心室功能未恢复,预后较差。
- 术前左室收缩末径增大和双侧胸廓内动脉移植分别与未恢复独立相关。
- 左心室功能未恢复与全因死亡风险显著增加独立相关。
核心结论
- 近40%缺血性心肌病CABG患者未实现左心室功能恢复,且与不良预后相关。
- 为实现左心室功能恢复,可考虑在左室重构过度发生前采用双侧胸廓内动脉CABG。
研究设计与样本
- 回顾性研究,纳入490例LVEF≤40%接受CABG的缺血性心肌病患者。
- 随访超声心动图于术后1个月、1年及每年进行,临床随访完成461例(94.1%),平均随访64.5±45.5个月。
主要发现
- 随访期间超声心动图评估1863次(平均3.8±2.4次),193例(39.4%)左心室功能未恢复。
- 10年总生存率恢复组53.9%显著高于未恢复组31.4%(P<0.001)。
- 左心室功能未恢复的独立预测因素包括术前左室收缩末径(OR 1.07,95%CI 1.04-1.10;P<0.001)和双侧胸廓内动脉移植(OR 0.61,95%CI 0.39-0.95;P=0.028)。
- 多变量Cox比例风险模型中,左心室功能未恢复与全因死亡显著相关(HR 2.14,95%CI 1.60-2.86;P<0.001)。
关键数值与推荐
- 左心室功能恢复定义为随访期间至少一次EF≥40%。
- 左心室功能未恢复定义为任何随访时EF<40%。
临床怎么用
- 对缺血性心肌病CABG患者应规律超声随访评估左心室功能恢复状态。
- 术前左室收缩末径较大者需关注左室重构程度,双侧胸廓内动脉移植可能与更高恢复率相关。
局限性
- 本研究为回顾性设计。
- 临床随访未覆盖全部490例患者(完成461例,94.1%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This retrospective study aimed to clarify the incidence, determinants and clinical impact of left ventricular (LV) function non-recovery after coronary artery bypass grafting (CABG) in patients with ischaemic cardiomyopathy. METHODS: A total of 490 patients with ischaemic cardiomyopathy (LV ejection fraction ≤ 40%) undergoing CABG were analysed. Follow-up echocardiography was performed at 1 month, 1 year, and annually thereafter. LV function recovery was defined as ejection fraction (EF) ≥40% at least once during follow-up. LV function non-recovery was defined as EF <40% at any follow-up. The primary and secondary end points were changes in LV function and all-cause mortality, respectively. Clinical follow-up was completed in 461 patients (94.1%; mean follow-up: 64.5 ± 45.5 months). RESULTS: During follow-up, echocardiographic assessments were performed 1863 times (mean, 3.8 ± 2.4), and 193 patients (39.4%) exhibiting LV function non-recovery were identified. Overall survival was significantly higher in the recovery group (53.9%) than in the non-recovery group (31.4%) at 10 years (P < 0.001). Independent predictors of LV function non-recovery were preoperative LV end-systolic diameter [odds ratio (OR) 1.07, 95% confidence interval (CI) 1.04-1.10; P < 0.001] and bilateral internal thoracic artery grafting (OR 0.61, 95% CI 0.39-0.95; P = 0.028). In a multivariable Cox proportional hazards model, LV function non-recovery was significantly associated with all-cause mortality (hazard ratio 2.14, 95% CI 1.60-2.86; P < 0.001). CONCLUSIONS: Almost 40% of patients with ischaemic cardiomyopathy undergoing CABG did not achieve LV function recovery and were associated with poor prognosis. To achieve LV function recovery, CABG with bilateral internal thoracic artery may be recommended before excessive LV remodelling occurs. CLINICAL TRIAL REGISTRATION NUMBER: Institutional review board of Osaka University Hospital, number 16105.
引用
- Nakae M, Kainuma S, Toda K, et al. Incidence, determinants and clinical impact of left ventricular function recovery after surgical treatments for ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2021. PMID: 33779701. doi:10.1093/ejcts/ezab122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。